Abstract
Macropinocytosis can be induced in several cell types by stimulation with growth factors. In selected cell types, notably macrophages and dendritic cells, macropinocytosis occurs constitutively, supporting the uptake of antigens for subsequent presentation. Despite their different mode of initiation and contrasting physiological roles, it is tacitly assumed that both types of macropinocytosis are mechanistically identical. We report that constitutive macropinocytosis is stringently calcium dependent, while stimulus-induced macropinocytosis is not. Extracellular calcium is sensed by G-protein-coupled calcium-sensing receptors (CaSR) that signal macropinocytosis through Gα-, phosphatidylinositol 3-kinase and phospholipase C. These pathways promote the recruitment of exchange factors that stimulate Rac and/or Cdc42, driving actin-dependent formation of ruffles and macropinosomes. In addition, the heterologous expression of CaSR in HEK293 cells confers on them the ability to perform constitutive macropinocytosis. Finally, we show that CaSR-induced constitutive macropinocytosis facilitates the sentinel function of macrophages, promoting the efficient delivery of ligands to cytosolic pattern-recognition receptors.
Macropinocytosis can be induced in several cell types by growth factors to promote nutrient acquisition. Here the authors find that constitutive macropinocytosis, unique to dendritic cells and macrophages, requires the activity of calcium-sensing receptors.
Macropinocytosis is an actin-driven process whereby cells internalize large volumes of extracellular fluid, generating phase-bright vacuoles (>250 nm). Many cell types generate such vacuoles, known as macropinosomes, in response to growth factor stimulation. In these instances, macropinocytosis is intended for nutrient acquisition, representing a major amino-acid supply route that enables cell growth1. Other proposed functions include recycling of adhesion receptors to the leading edge of migratory cells2, bulk membrane retrieval3 and growth cone collapse in nerve cells4.
To trigger macropinocytosis, growth factors remodel the lipid microenvironment. Phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) is converted to phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) and in parallel also hydrolysed into diacylglycerol (DAG) and inositol 3,4,5-trisphosphate (Ins(3,4,5)P3) by phospholipase Cγ (PLCγ)5,6,7. The subsequent conversion of DAG to phosphatidic acid (PtdOH) by diacylglycerol kinase and the sequential breakdown of PtdIns(3,4,5)P3 into phosphatidylinositol 3,4-bisphosphate and finally phosphatidylinositol 3-phosphate are required for the completion of macropinocytosis7,8.
The spatially and temporally restricted changes in lipid composition contribute to the recruitment of several protein effectors, including guanine nucleotide exchange factors (GEFs) that control the activity of Rho-family GTPases. One such GEF, T-cell lymphoma invasion and metastasis-inducing protein 1 (TIAM1), has both a PtdIns(3,4,5)P3-binding PH domain and a PtdOH-interacting polybasic domain that mediate its recruitment to nascent ruffles8,9. The consequent activation of Rac1 promotes the formation of branched actin networks that drive membrane extensions and macropinocytic cup formation. Other Rho family GTPases, such as Cdc42 and RhoG, are also required for macropinocytosis, although details of their function remain less clear10,11.
Although macropinocytosis can be induced in a variety of cell types by growth factors and other stimuli, dendritic cells (DCs) and macrophages share a unique behaviour: they perform macropinocytosis constitutively. This intrinsic process is astonishingly active: macrophages were estimated to internalize the equivalent of their entire cell surface every 33 min (ref. 12), while human DCs take up >1,000 μm (ref. 3) of extracellular fluid—roughly 40% of the volume of the cell—every hour13. This feature allows for the continuous capture of antigens, which are processed and presented to the adaptive immune system. Despite their different mode of initiation and contrasting physiological roles, it is tacitly assumed that stimulus induced and constitutive macropinocytosis are mechanistically identical. To date, however, the molecular mechanisms underlying these two modes have not been formally compared. Here we identify key differences between constitutive and growth factor-induced macropinocytosis in primary phagocytes. In particular, a major distinguishing feature—the requirement for extracellular calcium—is studied in detail and reveals the involvement of calcium-sensing receptors in constitutive macropinocytosis.
Results
Macrophages perform distinct modes of macropinocytosis
Unstimulated DCs and macrophages undergo constitutive ruffling14. Convergence and closure of ruffles to form large cytosolic vacuoles has been documented in both cell types8,10. We explored whether this mode of constitutive macropinocytosis differs from that induced by growth factors. Large (70 kDa) dextran was used for our assays as it has been shown to be internalized exclusively via macropinocytosis, and not by other modes of endocytosis such as clathrin-coated pits or caveolae15. To ensure that this was indeed the case in myeloid cells, we compared the uptake of the large dextran by primary human monocyte-derived macrophages (hMDMs) that were either untreated, or were pretreated with latrunculin A (an actin disruptor) or with Clostridium difficile toxin B (an inhibitor of small Rho GTPases), agents shown earlier to block macropinocytosis16,17. The uptake of 70 kDa dextran, which is patent in unstimulated hMDMs (Fig. 1; Supplementary Figs 1 and 2a) was obliterated by either latrunculin or C. difficile toxin B (Supplementary Fig. 2a). Under these conditions, uptake of transferrin—a canonical clathrin-dependent cargo18—proceeded normally, and the distribution of early (Rab5-positive) and late (LAMP1-positive) endosomal compartments was unaffected (Supplementary Fig. 2a–c). These observations validate the use of 70 kDa dextran to monitor macropinocytosis in macrophages.
We proceeded to compare constitutive and growth factor-stimulated macropinocytosis. To analyse constitutive macropinocytosis hMDMs were bathed in serum-free medium for the duration of the dextran uptake period (15 min; similar results were obtained when the cells were, in addition, preincubated in the absence of serum for up to 16 h). hMDMs formed numerous cytosolic vacuoles containing 70 kDa dextran, whether incubated in the presence or absence of macrophage colony-stimulating factor (M-CSF; Fig. 1a). The size of the resultant macropinosomes was, however, different under both conditions: vacuoles larger than 3 μm were often formed when M-CSF was present, while smaller macropinosomes were generated in its absence (Fig. 1a). We applied a lower size cutoff of 0.75 μm to exclude endosomes and set an arbitrary size threshold at 3 μm to distinguish between the two forms of macropinocytosis (Fig. 1b). Note that macropinosomes smaller than 3 μm were observed under both conditions and their frequency was unaltered by M-CSF. In contrast, the number of macropinosomes larger than 3 μm was negligible in the absence of M-CSF, but increased on exposure to the growth factor (Fig. 1c,d). These observations suggest that the thresholding approach appropriately distinguished between macropinosomes formed constitutively and those induced by M-CSF. While the 15 min allowed for dextran uptake yielded large and reliable signals, it was conceivable that the occurrence of fusion or fission events during this period made the quantification of macropinosomes inaccurate. However, we found that a much shorter uptake period (3 min) yielded very similar results (Supplementary Fig. 1a–d). Moreover, we monitored macropinosomes loaded by 1-min incubation with 70 kDa dextran for the subsequent 15 min and found that while their size decreased and fluorescence intensity increased—likely as a consequence of fission of small vesicles devoid of dextran—their number was not significantly altered (Supplementary Fig. 1e,f), and that they mix minimally with the late endosomal compartment (Supplementary Movie 1). Altogether, these findings validate the accuracy of the method used to quantify macropinosome formation.
We next confirmed that, under the conditions described above, the vacuoles containing dextran were bona fide macropinosomes. Macropinocytosis is typically defined as an amiloride sensitive, phosphatidylinositol 3-kinase (PtdIns3K)- and actin-dependent process19. Using the amiloride derivatives HOE-694 and 5-(N-ethyl-N-isopropyl)amiloride (EIPA), the PtdIns3K inhibitor LY294002 and the actin-disrupting agent latrunculin A, we assessed whether the vacuoles formed fulfilled the canonical definition of macropinosomes. Both the constitutive and stimulated forms of macropinocytosis were sensitive to the drugs tested, with the exception that the smaller (<3 μm) vacuoles were less sensitive to the amiloride derivatives than anticipated (Fig. 1e,f). The latter observation is reminiscent of earlier reports where the constitutive uptake of fluid by immature DCs was found to be similarly unaffected by amiloride derivatives20. Altogether, these observations establish that there are two morphologically distinct modes of macropinocytosis in hMDMs and that these can be further distinguished by their sensitivity to amiloride derivatives.
Constitutive macropinocytosis requires extracellular Ca2+
Our results suggest that macropinocytosis is more heterogeneous than previously appreciated. In this regard it resembles phagocytosis, which encompasses a variety of processes that while sharing some gross phenotypic properties, differ in their molecular mechanism. For instance, some forms of phagocytosis require calcium while others do not21. We used this criterion to establish whether the constitutive and M-CSF-induced forms of macropinocytosis are distinct. It is worth noting that calcium is required for optimal M-CSF signalling22. Strikingly, and contrary to our expectation, removal of extracellular calcium abolished the constitutive form of macropinocytosis, but did not affect M-CSF-induced macropinocytosis (Fig. 2a–c; Supplementary Fig. 1a–d). Similar results were obtained when, instead of counting the number of macropinosomes formed, the quantity of 70 kDa dextran taken up was assessed by flow cytometry (Supplementary Fig. 3a–c). The effect was reversible, as the readdition of calcium to cells in calcium-free medium restored constitutive macropinocytosis (Fig. 2d). By contrast, removal of extracellular calcium did not affect the uptake of transferrin, nor the distribution of Rab5 and LAMP1, indicating that other forms of endocytosis remained unaltered (Supplementary Fig. 2a–c).
The preceding results imply that constitutive macropinocytosis is a calcium-dependent event; indeed, the rate of macropinocytosis was directly correlated to the concentration of extracellular calcium (Fig. 2e). To ensure that this feature is common to phagocytes from other species, we tested murine bone marrow-derived macrophages (mBMDMs); these cells proved to be equally sensitive to omission of calcium (Supplementary Fig. 3d; Fig. 2g), as were human monocyte-derived dendritic cells (hMDDCs; Fig. 2f,g), which also perform macropinocytosis constitutively8,20. We also tested A431 cells, an epidermal cell line that expresses high levels of the epidermal growth factor (EGF) receptor. In these cells macropinocytosis is negligible in the absence of growth factors, but it is greatly stimulated by addition of EGF (Fig. 2h,i). Removal of calcium had no effect on the induction of macropinocytosis by EGF (Fig. 2h,i). Altogether these data demonstrate that the constitutive form of macropinocytosis in phagocytes requires extracellular calcium; by contrast, growth factor-induced macropinocytosis is calcium independent.
[Ca2+] i does not affect constitutive macropinocytosis
Influx of extracellular calcium is an essential component of cytosolic calcium ([Ca2+]i) homeostasis. Removal of external calcium eliminates [Ca2+]i transients that result from influx across the plasmalemma, and causes a progressive decrease in the steady state [Ca2+]i. Alterations in [Ca2+]i, a well acknowledged second messenger, can conceivably account for the impairment of macropinocytosis observed when external calcium was omitted. Indeed, a variety of Ca2+-dependent effectors, including myosin light-chain kinase23,24, protein kinase C5,25 and phospholipase C (PLC)26,27, are involved in both macropinocytosis and phagocytosis. To determine whether the effect of removing extracellular calcium on constitutive macropinocytosis was due to changes in [Ca2+]i, we monitored [Ca2+]i and the efficiency of macropinocytosis simultaneously; [Ca2+]i was measured by ratio imaging using Fura2. The removal of extracellular calcium had a minimal effect on [Ca2+]i within a timeframe relevant to the macropinocytosis uptake assays: [Ca2+]i was not significantly different when measured before and shortly (≈30 s) after external calcium removal (Fig. 3a,b). Even when measured after 15 min, the end point of the macropinocytosis determinations, [Ca2+]i had decreased by only 19 nM, from 107±4 nM to 88±3 nM (means±s.e. of 28 determinations; Supplementary Fig. 4a). Under these conditions, constitutive macropinocytosis was virtually abolished (Fig. 3b). We used thapsigargin to rule out the possibility that the minute change in basal [Ca2+]i that develops during the course of the assay was responsible for the inhibition of macropinocytosis. By inhibiting the Ca2+-ATPase, thapsigargin causes net release of calcium from the endoplasmic reticulum. In cells bathed in calcium-free medium, this is manifested as an increase in [Ca2+]i (Fig. 3a and Supplementary Fig. 4b). While the increase is transient, it nevertheless suffices to maintain [Ca2+]i above the baseline level throughout the macropinocytosis assay. This enabled us to test the effects of external calcium removal under conditions where [Ca2+]i did not decrease. As shown in Fig. 3b, macropinocytosis was nevertheless obliterated. These findings imply that the inhibitory effect of calcium removal is not attributable to decreased [Ca2+]i, and suggest that [Ca2+]i transients do not suffice to induce macropinocytosis.
It was conceivable that juxtamembrane rapid [Ca2+]i transients, not detectable by global measurements of [Ca2+]i were responsible for macropinocytosis. We used 1,2-bis (2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA), a fast calcium chelator, to evaluate this possibility. We loaded cells with BAPTA and confirmed that the chelator effectively buffered [Ca2+]i transients. As illustrated in Fig. 3a, the [Ca2+]i elevation normally induced by thapsigargin was eliminated when cells were preloaded with BAPTA. Importantly, buffering [Ca2+]i with BAPTA had no effect on constitutive macropinocytosis (Fig. 3b). These experiments demonstrate that the inhibition of constitutive macropinocytosis associated with external calcium removal was not caused by elimination of [Ca2+]i transients or by reduction in the resting level of [Ca2+]i. Instead, extracellular calcium appears to be exerting its effect on the outer surface of the cell.
CaSR is necessary for constitutive macropinocytosis
In specialized cell types, the level of extracellular calcium is monitored by a G-protein-coupled receptor, CaSR. CaSR is expressed in myeloid cells, where it has been implicated in the activation of the inflammasome pathway28. We therefore considered the possibility that CaSR was involved in constitutive macropinocytosis. We initially confirmed that CaSR is expressed in macrophages: unlike HEK293, which were shown earlier to lack CaSR29, transcript encoding the receptor was readily detectable by RT–PCR in hMDMs (Fig. 4a). We next investigated whether activation of CaSR sufficed to elicit macropinocytosis. To this end we used HEK293 cells, which lack the receptor and do not normally perform macropinocytosis (top panel, Fig. 4d). We first confirmed that a fraction of the heterologously expressed CaSR was able to traffic to the plasma membrane in these cells. A CaSR fusion protein containing an extracellular superecliptic phluorin (SeP) tag was readily detected on the surface of non-permeabilized HEK293 cells using an anti-GFP antibody (Fig. 4b). Strikingly, heterologous expression of CaSR not only induced vigorous ruffling in HEK293 cells, as reported29, but sufficed to induce constitutive macropinocytosis (Fig. 4c,d). Using flow cytometry we determined that CaSR-expressing cells accumulated 70 kDa dextran preferentially, compared to untransfected HEK293 cells (Fig. 4e,f). As anticipated, the constitutive macropinocytosis of CaSR-expressing HEK293 cells was reduced by removal of extracellular calcium (Supplementary Fig. 5a).
That CaSR is in fact responsible for constitutive macropinocytosis in myeloid cells was verified using NPS2143, a selective antagonist of the receptor30. Exposure of hMDMS to NPS2143 resulted in a dose-dependent inhibition of constitutive macropinocytosis (Fig. 4g,h), accompanied by elimination of the spontaneous ruffling (Supplementary Movie 2 and 3). NPS2143 also potently inhibited constitutive macropinocytosis in hMDDCs (Fig. 4h, inset). Similar results were obtained with a second, structurally unrelated CaSR inhibitor, namely Calhex 231, which was somewhat less effective than NPS2143 (Supplementary Fig. 5b). As with the removal of external calcium, NPS2143 treatment did not alter the uptake of transferrin or the distribution of Rab5 and LAMP1, indicating that other forms of endocytosis were unaffected (Supplementary Fig. 2a–c). Last and consistent with the findings made when external calcium was removed, exposure of hMDMs to NPS2143 did not affect growth factor-induced macropinocytosis (Fig. 4i).
Although suggestive, this pharmacological evidence is not conclusive, due to possible off-target effects of these drugs. More definitive evidence of the involvement of CaSR in constitutive macropinocytosis was obtained by silencing the expression of the receptors with siRNA. Using electroporation, we achieved a ≈70% reduction in the levels of CaSR transcript, as determined by quantitative PCR, in hMDMs (Fig. 4j). This was accompanied by a commensurate reduction in the macropinocytic efficiency (Fig. 4j). Collectively, these experiments demonstrate that CaSR is required for constitutive macropinocytosis in macrophages.
CaSR signals constitutive macropinocytosis via Gα
Like other serpentine receptors, CaSR couples to heterotrimeric G proteins. To assess the involvement of G proteins in macropinocytosis we used the recently described pan-Gα inhibitor, BIM46187 (refs 31, 32), and the Gαi inhibitor, pertussis toxin (PTX). BIM46187 potently inhibited constitutive macropinocytosis, indicating a requirement for Gα-dependent signalling (Fig. 5a,b). PTX also inhibited macropinocytosis, albeit to a lesser extent, suggesting that Gαi-dependent signalling is at least partially involved (Fig. 5b). The observed inhibition could have resulted from suppression of a stimulatory signal, or from the generation of an inhibitory signal. Cytosolic 3′-5′-cyclic AMP (cAMP) levels are controlled by both stimulatory (Gαs) and inhibitory (Gαi) G proteins, and inhibition of the latter is anticipated to elevate cAMP. Increased cAMP could conceivably account for the observations, because it controls the phosphorylation and activity of vasodilator-stimulated phosphoprotein (VASP), a regulator of actin filament elongation; of note, VASP has been implicated in the reorganization of the actin cytoskeleton that underlies macropinocytosis33. Indeed, we found that removal of calcium or inhibition of CaSR by NPS2143 increased the phosphorylation of VASP, likely due to stimulation of protein kinase A activity in response to elevated cAMP34 (Fig. 5c). However, an even greater increase in VASP phosphorylation, induced by direct stimulation of adenylyl cyclase with forskolin, had no effect on constitutive macropinocytosis (Fig. 5d). These observations imply that the inhibitory effects of BIM46187 and PTX on macropinocytosis are not a consequence of the increase in cAMP.
CaSR signals macropinocytosis via PtdIns3Kγ and PLCγ
Generation of PtdIns(3,4,5)P3 is required for the completion of macropinocytosis7,35,36. We explored whether PtdIns3K is involved in the activation of constitutive macropinocytosis by CaSR. It is noteworthy that the Gα subunit of heterotrimeric G proteins, which was shown above to be engaged by CaSR, can activate PtdIns3Kγ (refs 37, 38). By transfecting into hMDMs a biosensor consisting of the PH domain of Akt fused to green fluorescent protein (GFP) (PH(Akt)-GFP), we detected the presence of PtdIns(3,4,5)P3 at the plasma membrane, with noticeable enrichment at sites of ruffling (Fig. 6a; Supplementary Movie 4). Strikingly, removal of extracellular calcium or pharmacological inhibition of CaSR resulted in depletion of PtdIns(3,4,5)P3 from the membrane and loss of membrane ruffles (Fig. 6a; Supplementary Movie 5). The accumulation of PtdIns(3,4,5)P3 in ruffles required Gα-dependent signalling, as BIM46187 caused dissociation of PH(Akt)-GFP from the plasma membrane and loss of ruffles (Fig. 6b). These data suggest that tonic stimulation of CaSR is required to maintain PtdIns3K activity in resting hMDMs. To determine whether PtdIns3Kγ was responsible for the generation of PtdIns(3,4,5)P3 and the macropinocytosis induced by CaSR, we treated hMDMs with AS605240, a PtdIns3Kγ-specific inhibitor. AS605240 caused a dose-dependent decrease in constitutive macropinocytosis (Fig. 6c). We also generated mBMDMs from PtdIns3Kγ knockout mice and compared the efficiency of macropinocytosis to mBMDMs isolated from wild-type mice. Constitutive macropinocytosis was markedly reduced in mBMDMs lacking PtdIns3Kγ (Fig. 6d).
The generation of PtdIns(3,4,5)P3 fosters the recruitment of PLCγ through its PH domain. PLCγ, along with PtdIns3K activity, serves to deplete PtdIns(4,5)P2 from sites of macropinocytosis, allowing for the release of PtdIns(4,5)P2-binding proteins and actin remodelling39. Indeed, blocking PLC with U73122 causes inhibition of growth factor-induced macropinocytosis in epithelial cells40. Inhibition of PLC also inhibited constitutive macropinocytosis in hMDMs (Fig. 6e). PLC catalyses the hydrolysis of PtdIns(4,5)P2, releasing DAG that can be converted by diacylglycerol kinases into PtdOH; the latter is required for constitutive macropinocytosis in dendritic cells8. Using a biosensor consisting of the Spo20p domain fused to GFP (GFP-2PABD)8, we confirmed the presence of PtdOH at the plasma membrane and in membrane ruffles of hMDMs (Fig. 6f). The generation of DAG by PLC is required for PtdOH accumulation, since U73122 treatment resulted in detachment of the GFP-2PABD probe from the membrane (Fig. 6f). Importantly, inhibition of CaSR signalling by removal of extracellular calcium or by addition of NPS2143 also resulted in loss of PtdOH from the membrane (Fig. 6g). These data support a pathway in which the Gα-dependent activation of PtdIns3Kγ upon CaSR stimulation results in the generation of PtdIns(3,4,5)P3 at the plasma membrane, which in turn recruits PLCγ, allowing for the hydrolysis of PtdIns(4,5)P2 and the generation of DAG and PtdOH that facilitate constitutive macropinocytosis8.
Inhibition of CaSR impairs constitutive ruffling
PtdIns(3,4,5)P3 and PtdOH at the membrane serve to recruit GEFs that activate Rho-family GTPases such as Rac1 (ref. 8); this in turn can initiate membrane ruffling and macropinocytosis. To establish whether CaSR utilizes this pathway we compared the actin cytoskeleton and assessed the activation of GTPases in control and NPS2143-treated hMDMs. Phalloidin staining revealed clearly defined cortical F-actin and F-actin-rich membrane ruffles extending from the surface of untreated hMDMs (Fig. 7a). In NPS2143-treated cells the band of cortical F-actin was thinner, abnormal F-actin puncta appeared in the cytoplasm, and virtually no actin-containing ruffles were observed (Fig. 7a). Differential interference contrast microscopy of live cells confirmed that dynamic membrane ruffling was arrested by NPS2143 (Supplementary Movies 2 and 3).
Rac1 and Cdc42 are thought to drive the actin remodelling required for macropinocytosis17. To monitor the activation state of these GTPases we employed a construct encoding PAK(PBD), a biosensor for GTP-bound Rac1 and Cdc42. hMDMs electroporated with PAK(PBD) conjugated to YFP were imaged under control and calcium-free conditions, as well as immediately after treatment with NPS2143. As expected, PAK(PBD) accumulated robustly and in a highly localized fashion in the membranes subtending macropinocytic ruffles in control cells (Fig. 7b; Supplementary Movie 6). In sharp contrast, the biosensor dissociated from the plasmalemma and became exclusively cytosolic when calcium was removed or when CaSR was inhibited (Fig. 7b; Supplementary Movie 7). These results strongly suggest that CaSR-driven signals promote activation of Rac1 and/or Cdc42. Consistent with this, we found that macropinosome formation by hMDMs was profoundly depressed by C. difficile toxin B which is known to inhibit Rac1 and Cdc42 (as well as other members of the Rho-GTPase family)41, but not by the C3 toxin of Clostridium botulinum that specifically inhibits RhoA (Fig. 7c). These data imply that CaSR-dependent activation of Rac and/or Cdc42 is implicated in constitutive membrane ruffling and macropinocytosis in hMDMs.
Macropinocytosis facilitates the uptake of NOD2 ligands
Extracellular danger signals sensed by pattern-recognition receptors such as nucleotide-binding oligomerization domain-containing protein 1 (NOD1) and 2 (NOD2) initially enter the endocytic pathway before reaching the cytosolic compartment42. NOD ligands are transported in a pH-dependent manner across the membrane of endosomes/lysosomes by members of the solute carrier family of peptide transporters—SLC15A3 and SLC15A4 (ref. 42). Because large volumes of extracellular fluid are internalized in macrophages and DCs via macropinocytosis, we analysed the possible role of CaSR and of constitutive macropinocytosis in the uptake of ligands that activate pattern-recognition receptors. Fifteen minutes after being added to the medium bathing hMDMs, the fluorescently labelled NOD2 ligand muramyl dipeptide (MDP) was taken up into endomembrane vesicles; MDP was also detectable in the cytosol (Fig. 8a), presumably as a result of transport across endomembranes by peptide transporters42. That the ligand was being effectively sensed by NODs was indicated by the robust phosphorylation of the p65 subunit of NFκB induced by MDP (Fig. 8b,c). Strikingly, inhibition of CaSR by the removal of external calcium or with NPS2143 drastically reduced the phosphorylation of p65 elicited by MDP (Fig. 8b,c). This suggested that inhibition of CaSR-dependent constitutive macropinocytosis reduces the amount of MDP taken up and subsequently translocated to the cytosol for sensing.
To ensure that the reduction in p65 phosphorylation caused by NPS2143 was due to impaired macropinocytosis, as opposed to non-specific effects of the drug on the NFκB signalling cascade, we incubated hMDMs with lipopolysaccharide (LPS) that stimulates NFκB through Toll-like receptor 4 (TLR4). TLR4 senses LPS at the cell surface and does not require internalization. As shown in Fig. 8d, LPS (0.5 μg ml−1) induced robust phosphorylation of p65. Importantly, treatment with NPS2143 had no discernible effect on LPS-induced p65 phosphorylation (Fig. 8d). Comparable results were obtained using lower concentrations of LPS (10 ng ml−1; Supplementary Fig. 6). To ensure that the stimulation was not caused by LPS internalization due to macropinocytosis, we also performed similar experiments in cells treated with either latrunculin A or NPS2143. The inhibition of CaSR-dependent macropinocytosis or of macropinocytosis in general had no significant effect on LPS-induced phosphorylation of p65 (Supplementary Fig. 6). Altogether, these data demonstrate that constitutive macropinocytosis, which is initiated and maintained by CaSR, aids in the sentinel function of phagocytes by facilitating the uptake of pattern-recognition receptor ligands.
Discussion
Unlike most cell types, DCs and macrophages display constitutive macropinocytosis, a unique behaviour that appears well suited for their sentinel function. This distinguishing feature has been proposed to serve as a mechanism for the acquisition of antigen for presentation on class I and II major histocompatibility molecules13,20,43. Indeed, inhibition of macropinocytosis markedly reduces the efficiency of antigen presentation by DCs both in vitro and in vivo44. The signals that initiate and maintain this constitutive process, however, have remained largely unknown. Here we show that extracellular calcium is a key stimulant of the signalling pathways that trigger constitutive macropinocytosis in macrophages and DCs. Further, we identify CaSR as the receptor that senses extracellular calcium and initiates the aforementioned signalling pathways.
CaSR is ubiquitous, but is expressed at particularly high levels in the parathyroid gland and kidney45,46, where it plays a critical role in extracellular calcium homeostasis. In myeloid osteoclast precursors CaSR directs migration towards bones, allowing for the initiation of bone remodelling47. CaSR, however, is also expressed in a number of tissues that are seemingly not involved in calcium homeostasis45, including monocytes, macrophages and DCs28,48, where it has been speculated to regulate immune function by controlling the activation of the inflammasome28. Our findings extend the immune function of CaSR in myeloid cells. It is relevant that extracellular calcium is elevated at sites of inflammation and injury49. CaSR may function in the migration towards, and acquisition of antigen at sites of injury and inflammation, thereby assisting the immune surveillance function of antigen-presenting cells.
Although previous work identified various signalling intermediates required for constitutive macropinocytosis, such as PtdIns3K, PLC and Rac1, efforts to identify the initiating event had failed8. We show here that CaSR can trigger the pathways that underlie constitutive macropinocytosis. We demonstrate that removal of extracellular calcium or pharmacological inhibition of CaSR block the steady state formation of PtdIns(3,4,5)P3 as well as the constitutive activation of Rac1/Cdc42 (Figs 6 and 7). The activation of PtdIns3K facilitates the recruitment of PLC, which, in turn, catalyses the formation of DAG at the plasma membrane. DAG not only activates protein kinase C, but can be converted to PtdOH by diacylglycerol kinases. The generation of PtdOH—which can recruit Rac GEFs bearing a polybasic domain, such as TIAM1—is a requirement for constitutive macropinocytosis8. In accordance with this model, inhibition of CaSR depletes PtdOH from the plasma membrane (Fig. 6g). We believe that the impaired activity of Rac1/Cdc42 on inhibition of CaSR (Fig. 7b) is due to diminished recruitment of PtdOH-responsive GEFs. This proposal is consistent with observations we made in hMDMs transfected with a TIAM1-GFP construct: in otherwise untreated cells TIAM1-GFP localized to the plasma membrane, where it induced pronounced membrane ruffling (Supplementary Movie 8). Interestingly, the machinery for constitutive macropinocytosis seems to be present in most cells, as the heterologous expression of CaSR in HEK cells confers the ability to perform macropinocytosis to these otherwise quiescent cells (Fig. 4).
Calcium had also been reported to facilitate macropinocytosis during growth cone collapse in neurons (4). In this case, however, it appears that changes in cytosolic calcium—as opposed to stimulation of CaSR by exofacial calcium—are responsible for the observed effect, which was promoted by release of ryanodine-sensitive (endoplasmic reticulum) calcium stores. Whether extracellular calcium also contributes to macropinocytosis in this system or in transformed cells where Ras is mutated remains to be defined.
In addition to identifying its initiating factor, the present work provides some insight into the functional relevance of constitutive macropinocytosis. Unlike growth factor-induced macropinocytosis, which is coupled to an increased metabolic demand for cell growth and proliferation, constitutive macropinocytosis does not appear to support increased cellular metabolism and is likely to serve a very different function. To our knowledge, constitutive macropinocytosis is a unique feature of innate immune cells and, as discussed earlier, is coupled to the uptake of antigen13,20,43,44,50. Bulk fluid uptake, however, is not a particularly efficient mechanism for antigen internalization. In line with this, binding of antigens to specific receptors on B cells—immunoglobulins—increases the efficiency of their internalization and ultimate presentation to T cells ∼1,000-fold51. DCs and macrophages also express receptors to enhance the uptake of antigens, such as Fc and scavenger receptors.
We also showed a novel function for the constitutive macropinocytosis of innate immune cells. Specifically, constitutive macropinocytosis serves as a major conduit for the delivery of ligands sensed by pattern-recognition receptors. Indeed, inhibition of constitutive macropinocytosis—attained by blocking CaSR—drastically reduced the ability of hMDMs to sense the NOD2 ligand, MDP (Fig. 8). By analogy, we predict that macropinocytosis serves also to deliver ligands to TLRs located in endomembrane compartments, such as TLR7 and TLR9.
In summary, a major distinguishing feature between growth factor-induced and constitutive macropinocytosis is the requirement for extracellular calcium. Extracellular calcium is sensed by the G-protein-coupled receptor CaSR, which initiates a signalling cascade that allows for the constitutive extension of membrane ruffles and the formation of macropinosomes. These structures not only facilitate the uptake of antigens, but they also serve as a major route of uptake and delivery to the cytosol of pattern-recognition receptor ligands.
Methods
Reagents
Tetramethyl rhodamine-conjugated 70,000 MW dextran, Alexa Fluor 488 conjugated transferrin, EGF, Superscript VILO cDNA synthesis kit, and the anti-GFP antibody (catalogue number, A11120; dilution, 1:1,000) and Fura2-AM were acquired from Life Technologies (Carlsbad, CA, USA). 5-(N-ethyl-N-isopropyl)amiloride, LY294002, thapsigargin, NPS2143, Calhex 231, PTX, LPS, DAPI, latrunculin A, the anti-actin monoclonal antibody (catalogue number, A5441; dilution, 1:1,000) and the anti-tubulin monoclonal antibody (catalogue number, T5168; dilution, 1:1,000) were purchased from Sigma-Aldrich (St Louis, MO, USA). Human and murine recombinant M-CSF, IL-4 and GM-CSF were from Peprotech (Rocky Hill, NJ, USA). AS605240 was from Selleck Chemicals (Houston, TX, USA). EGTA and EDTA were from BioShop Canada (Burlington, ON, Canada). The phospho-VASP (catalogue number, 3111 S; dilution, 1:500) and phospho-p65 (catalogue number, 3033 S; dilution, 1:500) antibodies were from Cell Signaling Technology (Beverley, MA, USA). Forskolin and U73122 were from Tocris Bioscience (Bristol, UK). MDP and MDP-rhodamine were from InvivoGen (San Diego, CA, USA). C. difficile toxin B was purchased from TechLab (Blacksburg, VA, USA). Tat-C3 was from Cytoskeleton Inc. (Denver, CO, USA). Ionomycin was from EMD (Billerica, MA, USA). HOE-694 was the gift of Dr H.J. Lang (Aventis Pharma, Frankfurt am Main, Germany). The SeP-CaSR construct was provided by Dr Jeremy Henley (University of Bristol, Bristol, UK). BIM46187 was synthesized as described in ref. 29. The forward (5′-CAGGTATAATTTCCGTGGGT-3′) and reverse (5′-GTACTGGGAGATGAGTTCAC-3′) primers for the CaSR RT–PCR and the forward (5′-TTCCAATATGATTCCACCCA-3′) and reverse (5′- CATACCAGGAAATGAGCTTG-3′) primers for the GAPDH RT–PCR were purchased from Integrated DNA Technologies (Coralville, IA, USA). The GeneJET RNA purification kit was from Thermo Fisher Scientific (Waltham, MA, USA). The TaqMan gene expression mastermix and the CaSR TaqMan gene expression assay were from Applied Biosystems (Waltham, MA, USA).
Solutions
The calcium-free medium contained 1 mM KH2PO4, 154 mM NaCl, 5.6 mM Na2HPO4, 2 mM MgCl2, 2 mM EGTA and 10 mM glucose, pH 7.2 at 37 °C. The calcium-containing medium contained 1 mM KH2PO4, 154 mM NaCl, 5.6 mM Na2HPO4, 2 mM MgCl2, 2 mM CaCl2 and 10 mM glucose, pH 7.2 at 37 °C. The Na+-rich buffer contained 140 mM NaCl, 3 mM KCl, 1 mM MgCl2, 5 mM glucose, and 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) adjusted to pH 7.2 at 37 °C.
Macrophage and dendritic cell isolation and cell culture
For hMDMs and hMDDCs, peripheral blood mononuclear cells were isolated from the blood of healthy donors by density-gradient separation with Lympholyte-H (Cedarlane, Burlington, ON, Canada). Monocytes were separated from other mononuclear cells in the washed buffy coat by adherence to glass coverslips in 12-well plates at a density of 3.0 × 106 mononuclear cells per well. Monocytes were then cultured for 7 days in RPMI 1640 supplemented with 10% heat-inactivated fetal bovine serum, antibiotic/antimycotic (MultiCell, Wisent, St Bruno, Canada) and either 25 ng ml−1 GM-CSF+20 ng ml−1 IL-4 (for hMDDCs) or 25 ng ml−1 M-CSF (for hMDMs). The medium and cytokines on the cells were aspirated and replaced every 2–3 days.
For murine BMDMs, bone marrow was collected from the long bones of healthy wild-type or PtdIns3Kγ knockout mice. The PtdIns3Kγ knockout mice were generated52 and kindly provided by Dr J. M. Penninger (Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria). The precursor cells (plated at a density of 4.5 × 105 cells per 10-cm dish) were cultured in the presence of 10 ng ml−1 M-CSF in RPMI 1640 supplemented with 10% heat-inactivated fetal bovine serum and antibiotic/antimycotic for 7 days. The medium and cytokines on the plate were aspirated and replaced every 2–3 days.
A431 and HEK293 cells were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). Cells were maintained in DMEM (MultiCell, Wisent, St Bruno, Canada) supplemented with 10% heat-inactivated fetal bovine serum. When cultures reached confluence, they were detached using 0.05% trypsin-EDTA and replated on either coverslips for macropinocytosis assays or in flasks for maintenance.
Transfections
For hMDMs, DNA transfections were performed using the Neon transfection system (Life Technologies, Carlsbad, CA, USA). hMDMs were suspended using Accutase (Gibco, Life Technologies, Carlsbad, CA, USA) and the pellet was washed 3 ×. Transfections were performed according to the manufacturer's protocol. For siRNA transfections of hMDMs, the HiPerFect transfection reagent (Qiagen, Hilden, Germany) was used according to the manufacturer's protocol. For HEK cells, transfections were performed with the FuGENE 6 transfection reagent (Promega, Madison, WI, USA) according to the manufacturer's instructions.
PCR
To detect the expression of CaSR messenger RNA (mRNA) in hMDMs and HEK cells, one step RT–PCR was performed. RNA was purified from hMDMs and HEK cells using the GeneJet RNA purification kit (Thermo Fisher Scientific) and used as a template for the generation of complementary DNA (cDNA) and subsequent PCR amplification using the OneStep RT–PCR kit from Life Sciences according to the manufacturer's instructions. The primary sequences of the forward and reverse primers are listed in the ‘Reagents' section. The amplification products were visualized by electrophoresis on agarose gels prestained with ethidium bromide. Uncropped gels are presented in Supplementary Fig. 7a.
To quantify the expression of CaSR mRNA after siRNA knockdown, RNA was purified from hMDMs using the GeneJet RNA purification kit (Thermo Fisher Scientific) and used as a template for the generation of cDNA using the Superscript VILO cDNA synthesis kit (Life Technologies). The CaSR-specific Taqman gene expression assay (Life Technologies) was then used for real-time quantitative PCR to quantify the expression of CaSR, which was normalized relative to actin mRNA.
Macropinocytosis assay
Cells were plated on 18 mm coverslips 24 h before performing the macropinocytosis assay. In the case of drug treatments, cells were pretreated with their respective drugs for 1 h before the assay, except for PTX, Tat-C3 and C. difficile toxin B, which required 24, 4 and 4 h pretreatments, respectively. The concentrations for the drugs used are as follows: EIPA (10 μM), HOE-694 (10 μM), latrunculin A (2 μM), LY294002 (10 μM), PTX (0.1 μg ml−1), BIM46187 (10 μM), NPS2143 (1, 5, 10 or 20 μM), forskolin (10 μM), U73122 (1 μM), C. difficile toxin B (50 ng ml−1), Tat-C3 (10 μg ml−1) and AS605249 (5, 10 or 20 μM). After pretreatment, the medium was aspirated from the cells and replaced with either calcium-containing or calcium-free medium with rhodamine-conjugated 70 kDa dextran (25 μg ml−1) and either M-CSF (200 ng ml−1) or EGF (200 ng ml−1) where indicated. Cells were incubated at 37 °C for 15 min and then washed and imaged immediately. Imaging was done by spinning disk confocal microscopy on an Axiovert 200 M equipped with a 63 × objective and a separate 1.5 × magnifying lens (Carl Zeiss, Oberkochen, Germany). The microscope was fitted with a piezo focus drive and diode-pumped solid-state lasers (440, 491, 561, 638 and 655 nm; Spectral Applied Research, Richmond Hill, ON, Canada). Micrographs were acquired using a CCD camera (Hamamatsu Photonics, Hamamatsu, Japan) under the control of Volocity software. Macropinosomes were then counted from the acquired images using the measurement tool in the ImageJ software.
Intracellular calcium measurements
MDMs were loaded with Fura2-AM at a concentration of 3 μM in HBSS (MultiCell, Wisent, St Bruno, Canada) for 20 min at 37 °C. They were then washed with fresh HBSS 3 × and incubated at 37 °C for an additional 10 min. hMDMs were then placed into a magnetic Chamlide coverslip holder, covered in HBSS and placed onto the temperature controlled (37 °C) microscope stage. The hMDMs were imaged on a Leica DM IRB microscope (Leica, Wetzlar, Germany). Calcium measurements were done by fluorescence ratio imaging using a filtre wheel (Sutter Instruments, Novato, CA, USA) to rapidly switch between excitation filters. Fura2 was excited by light from an X-Cite 120 lamp (EXFO Photonic Solutions, Quebec, Canada) using dual excitation (340 and 380 nm) and single emission (510 nm). The emitted light was captured by a CCD camera (Cascade II; Photometrics, Tucson, AZ, USA). The filtre wheels, shutters and camera were controlled by the MetaFluor software (MDS Analytical Technologies, Sunnyvale, CA, USA).
After experimental measurements were taken, ionomycin was added at a concentration of 6 μM to acquire an Rmax (340/380) value for approximation of absolute [Ca2+]I values. The Grynkiewicz formula53 was used to convert the fluorescence ratios to [Ca2+]I values.
Immunoblotting
Cells were washed 3 × with ice-cold PBS and were subsequently lysed using a small volume of ice-cold RIPA buffer. Total protein concentration was calculated using the Bradford assay and 50 μg of protein of each sample was loaded and separated by 12% SDS–PAGE. The protein was transferred to a polyvinylidene difluoride (PVDF) membrane and blocked in Tris-buffered saline containing 0.05% Tween-20 (TBST) and 10% fat-free milk for 30 min. The primary antibody was added to the membrane in 2.5% milk in TBST for 1 h at room temperature and washed 3 × with TBST for 10 min each. The membrane was reblocked with 10% milk in TBST for 15 min and the HRP-conjugated secondary antibodies were added in 2.5% milk in TBST for 45 min. The membrane was washed 3 × with TBST for 10 min each and blot was visualized on the Odyssey Fc (LI-COR, Lincoln, NE, USA). Band intensity was quantified using the ImageStudio Lite software. Uncropped versions of all the gels presented can be seen in Supplementary Fig. 7.
Data presentation and statistics
Unless otherwise indicated, images are representative of (≥50) cells from at least three separate experiments. Data presented in text and graphs are the means plus standard error of at least three independent experiments. Unpaired t-tests were used to establish the significance of experimentally observed differences.
Additional information
How to cite this article: Canton, J. et al. Calcium-sensing receptors signal constitutive macropinocytosis and facilitate the uptake of NOD2 ligands in macrophages. Nat. Commun. 7:11284 doi: 10.1038/ncomms11284 (2016).
Supplementary Material
Acknowledgments
J.C. is a Cystic Fibrosis Canada postdoctoral fellow. D.S. was supported by a Cystic Fibrosis Canada studentship and a Restracomp Graduate Studentship from The Hospital for Sick Children. This work was supported by a Foundation Grant FDN-143202 and grants MOP93634 and TBO-122068 from the Canadian Institutes of Health Research awarded to S.G. and M. Glogauer.
Footnotes
Author contributions J.C. conceived the project, designed and performed the experiments, analysed the data and wrote the manuscript. D.S. designed and performed experiments and analysed the data. C.B. and M. Gütschow synthesized BIM46187. M. Glogauer helped design experiments and provided the PtdIns3Kγ knockout mice. S.G. conceived the project, designed the experiments, analysed the data and wrote the manuscript.
References
- Commisso C. et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature 497, 633–637 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gu Z., Noss E. H., Hsu V. W. & Brenner M. B. Integrins traffic rapidly via circular dorsal ruffles and macropinocytosis during stimulated cell migration. J. Cell Biol. 193, 61–70 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holt M., Cooke A., Wu M. M. & Lagnado L. Bulk membrane retrieval in the synaptic terminal of retinal bipolar cells. J. Neurosci. 23, 1329–1339 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kabayama H. et al. Ca2+ induces macropinocytosis via F-actin depolymerization during growth cone collapse. Mol. Cell Neurosci. 40, 27–38 (2009). [DOI] [PubMed] [Google Scholar]
- Welliver T. P. & Swanson J. A. A growth factor signaling cascade confined to circular ruffles in macrophages. Biol. Open 1, 754–760 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yoshida S., Hoppe A. D., Araki N. & Swanson J. A. Sequential signaling in plasma-membrane domains during macropinosome formation in macrophages. J. Cell Sci. 122, 3250–3261 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maekawa M. et al. Sequential breakdown of 3-phosphorylated phosphoinositides is essential for the completion of macropinocytosis. Proc. Natl Acad. Sci. USA 111, E978–E987 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bohdanowicz M. et al. Phosphatidic acid is required for the constitutive ruffling and macropinocytosis of phagocytes. Mol. Biol. Cell 24, 1700–1712 S1–7 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ceccarelli D. F. J. et al. Non-canonical interaction of phosphoinositides with pleckstrin homology domains of Tiam1 and ArhGAP9. J. Biol. Chem. 282, 13864–13874 (2007). [DOI] [PubMed] [Google Scholar]
- Garrett W. S. et al. Developmental control of endocytosis in dendritic cells by Cdc42. Cell 102, 325–334 (2000). [DOI] [PubMed] [Google Scholar]
- Ellerbroek S. M. et al. SGEF, a RhoG guanine nucleotide exchange factor that stimulates macropinocytosis. Mol. Biol. Cell 15, 3309–3319 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steinman R. M., Brodie S. E. & Cohn Z. A. Membrane flow during pinocytosis. A stereologic analysis. J. Cell Biol. 68, 665–687 (1976). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sallusto F., Cella M., Danieli C. & Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389–400 (1995). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Flannagan R. S., Harrison R. E., Yip C. M., Jaqaman K. & Grinstein S. Dynamic macrophage ‘probing' is required for the efficient capture of phagocytic targets. J. Cell Biol. 191, 1205–1218 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li L. et al. The effect of the size of fluorescent dextran on its endocytic pathway. Cell Biol. Int. 39, 531–539 (2015). [DOI] [PubMed] [Google Scholar]
- West M. A., Prescott A. R., Eskelinen E. L., Ridley A. J. & Watts C. Rac is required for constitutive macropinocytosis by dendritic cells but does not control its downregulation. Curr. Biol. 10, 839–848 (2000). [DOI] [PubMed] [Google Scholar]
- Koivusalo M. et al. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J. Cell Biol. 188, 547–563 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu A. P., Aguet F., Danuser G. & Schmid S. L. Local clustering of transferrin receptors promotes clathrin-coated pit initiation. J. Cell Biol. 191, 1381–1393 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kerr M. C. & Teasdale R. D. Defining macropinocytosis. Traffic 10, 364–371 (2009). [DOI] [PubMed] [Google Scholar]
- Norbury C. C., Chambers B. J., Prescott A. R., Ljunggren H. G. & Watts C. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27, 280–288 (1997). [DOI] [PubMed] [Google Scholar]
- Nunes P. & Demaurex N. The role of calcium signaling in phagocytosis. J. Leukoc. Biol. 88, 57–68 (2010). [DOI] [PubMed] [Google Scholar]
- Wang Y. et al. M-CSF Induces Monocyte Survival by Activating NF-κB p65 Phosphorylation at Ser276 via Protein Kinase C. PLoS ONE 6, e28081 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Olazabal I. M. et al. Rho-kinase and myosin-II control phagocytic cup formation during CR, but not FcgammaR, phagocytosis. Curr. Biol. 12, 1413–1418 (2002). [DOI] [PubMed] [Google Scholar]
- Jiang J., Kolpak A. L. & Bao Z.-Z. Myosin IIB isoform plays an essential role in the formation of two distinct types of macropinosomes. Cytoskeleton (Hoboken) 67, 32–42 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Allen L. A. & Aderem A. Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages. J. Exp. Med. 184, 627–637 (1996). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Botelho R. J. et al. Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J. Cell Biol. 151, 1353–1368 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Swanson J. A. Phorbol esters stimulate macropinocytosis and solute flow through macrophages. J. Cell Sci. 94, (Pt 1): 135–142 (1989). [DOI] [PubMed] [Google Scholar]
- Lee G.-S. et al. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492, 123–127 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bouschet T., Martin S., Kanamarlapudi V., Mundell S. & Henley J. M. The calcium-sensing receptor changes cell shape via a beta-arrestin-1 ARNO ARF6 ELMO protein network. J. Cell Sci. 120, 2489–2497 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nemeth E. F. et al. Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone. J. Pharmacol. Exp. Ther. 299, 323–331 (2001). [PubMed] [Google Scholar]
- Ayoub M. A. et al. Inhibition of heterotrimeric G protein signaling by a small molecule acting on Galpha subunit. J. Biol. Chem. 284, 29136–29145 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schmitz A.-L. et al. A cell-permeable inhibitor to trap Gαq proteins in the empty pocket conformation. Chem. Biol. 21, 890–902 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saeed M. F., Kolokoltsov A. A., Albrecht T. & Davey R. A. Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog. 6, e1001110 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Benz P. M. et al. Cytoskeleton assembly at endothelial cell-cell contacts is regulated by alphaII-spectrin-VASP complexes. J. Cell Biol. 180, 205–219 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Araki N., Johnson M. T. & Swanson J. A. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J. Cell Biol. 135, 1249–1260 (1996). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Amyere M. et al. Constitutive macropinocytosis in oncogene-transformed fibroblasts depends on sequential permanent activation of phosphoinositide 3-kinase and phospholipase C. Mol. Biol. Cell 11, 3453–3467 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stoyanov B. et al. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269, 690–693 (1995). [DOI] [PubMed] [Google Scholar]
- Hirsch E. et al. Signaling through PI3Kγ: a common platform for leukocyte, platelet and cardiovascular stress sensing. Thromb. Haemost. 95, 29–35 (2005). [PubMed] [Google Scholar]
- Scott C. C. et al. Phosphatidylinositol-4,5-bisphosphate hydrolysis directs actin remodeling during phagocytosis. J. Cell Biol. 169, 139–149 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Araki N., Egami Y., Watanabe Y. & Hatae T. Phosphoinositide metabolism during membrane ruffling and macropinosome formation in EGF-stimulated A431 cells. Exp. Cell Res. 313, 1496–1507 (2007). [DOI] [PubMed] [Google Scholar]
- Jank T., Giesemann T. & Aktories K. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 17, 15R–22R (2007). [DOI] [PubMed] [Google Scholar]
- Nakamura N. et al. Endosomes are specialized platforms for bacterial sensing and NOD2 signalling. Nature 509, 240–244 (2014). [DOI] [PubMed] [Google Scholar]
- West M. A. et al. Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science 305, 1153–1157 (2004). [DOI] [PubMed] [Google Scholar]
- von Delwig A. et al. Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice. Arthritis Res. Ther. 8, R93 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goltzman D. & Hendy G. N. The calcium-sensing receptor in bone—mechanistic and therapeutic insights. Nat. Rev. Endocrinol. 11, 298–307 (2015). [DOI] [PubMed] [Google Scholar]
- Aida K., Koishi S., Tawata M. & Onaya T. Molecular cloning of a putative Ca(2+)-sensing receptor cDNA from human kidney. Biochem. Biophys. Res. Commun. 214, 524–529 (1995). [DOI] [PubMed] [Google Scholar]
- Boudot C. et al. Implication of the calcium sensing receptor and the Phosphoinositide 3-kinase/Akt pathway in the extracellular calcium-mediated migration of RAW 264.7 osteoclast precursor cells. Bone 46, 1416–1423 (2010). [DOI] [PubMed] [Google Scholar]
- Olszak I. T. et al. Extracellular calcium elicits a chemokinetic response from monocytes in vitro and in vivo. J. Clin. Invest. 105, 1299–1305 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin C. Y. & Huang T. P. Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis. Nephron 59, 90–95 (1991). [DOI] [PubMed] [Google Scholar]
- Lim J. P., Teasdale R. D. & Gleeson P. A. SNX5 is essential for efficient macropinocytosis and antigen processing in primary macrophages. Biol. Open 1, 904–914 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Singer D. F. & Linderman J. J. The relationship between antigen concentration, antigen internalization, and antigenic complexes: modeling insights into antigen processing and presentation. J. Cell Biol. 111, 55–68 (1990). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sasaki T. et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 287, 1040–1046 (2000). [DOI] [PubMed] [Google Scholar]
- Grynkiewicz G., Poenie M. & Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440–3450 (1985). [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.